These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 43187)

  • 1. Striatal dopamine turnover and MIF-I.
    Kostrzewa RM; Fukushima H; Harston CT; Perry KW; Fuller RW; Kastin AJ
    Brain Res Bull; 1979; 4(6):799-802. PubMed ID: 43187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIF-I and postsynaptic receptor sites for dopamine.
    Kostrzewa RM; Hardin JC; Snell RL; Kastin AJ; Coy DH; Bymaster F
    Brain Res Bull; 1979; 4(5):657-62. PubMed ID: 39665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons.
    Kostrzewa RM; Spirtes MA; Klara JW; Christensen CW; Kastin AJ; Joh TH
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):125-7. PubMed ID: 13412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].
    Sheng JG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):213-5, 253. PubMed ID: 2575971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of systemic and intracerebroventricular domperidone treatment on striatal and hypothalamic dopaminergic neurons.
    Ferretti C; Benfenati F; Cimino M; Vantini G; Lipartiti M; Muccioli G; di Carlo R; Algeri S
    Med Biol; 1983; 61(6):331-6. PubMed ID: 6676604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cholinergic effect on the dopamine turnover in the rat corpus striatum].
    Oelszner W; Funk KF; Schwarzenfeld IV; Staib AH; Westermann KH
    Acta Biol Med Ger; 1975; 34(4):647-53. PubMed ID: 1189838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebral infusion of DOPAC decreases striatal dopamine.
    Shiekhattar R; Ghasemzadeh MB; Adams RN
    Brain Res Bull; 1992 Dec; 29(6):891-6. PubMed ID: 1473020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A biochemical study of cholinergic-dopaminergic interactions in the central nervous system.
    De Souza H; Palermo-Neto J
    Gen Pharmacol; 1985; 16(5):533-6. PubMed ID: 4054579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased striatal dopamine turnover following acute administration of rotenone to mice.
    Thiffault C; Langston JW; Di Monte DA
    Brain Res; 2000 Dec; 885(2):283-8. PubMed ID: 11102582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation of apomorphine action in rats by l-prolyl-l-leucyl-glycine amide.
    Kostrzewa RM; Kastin AJ; Sobrian SK
    Pharmacol Biochem Behav; 1978 Sep; 9(3):375-8. PubMed ID: 30981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine.
    Wong PT; Teo WL; Lee T
    Neuroreport; 1993 Oct; 5(1):53-6. PubMed ID: 7506588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-dopa and L-tyrosine on release of free and conjugated dopamine, homovanillic acid and dihydroxyphenylacetic acid from slices of rat striatum.
    Tyce GM; Rorie DK
    Life Sci; 1985 Dec; 37(25):2439-48. PubMed ID: 4079658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Jun; 37(2):249-55. PubMed ID: 954808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of beta-endorphin on striatal dopamine metabolism.
    Van Loon GR; Kim C
    Res Commun Chem Pathol Pharmacol; 1977 Sep; 18(1):171-4. PubMed ID: 905630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probenecid on endogenous and exogenous 3,4-dihydroxyphenylacetic acid and homovanillic acid in the rat brain.
    Broch OJ
    Eur J Pharmacol; 1976 Sep; 39(1):33-40. PubMed ID: 964303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of acute and subacute HA-966 treatment on storage and release of striatal dopamine.
    Broxterman HJ; Noach EL; Van Valkenburg CF
    Eur J Pharmacol; 1979 Dec; 60(2-3):153-61. PubMed ID: 527656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
    Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
    Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of depletion of striatal dopamine by alpha-methyl-m-tyrosine.
    Uretsky NJ; Snodgrass SR; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Dec; 195(3):465-79. PubMed ID: 490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.